Cargando…

Intratumoural injection of the toll-like receptor-2/6 agonist ‘macrophage-activating lipopeptide-2’ in patients with pancreatic carcinoma: a phase I/II trial

This phase I/II trial examined safety and efficacy of the toll-like receptor 2/6 agonist MALP-2 in combination with gemcitabine in patients with incompletely resectable pancreas carcinomas. MALP-2 is a toll-like receptor 2/6 agonist, acts as an immunological adjuvant, and has been described recently...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt, J, Welsch, T, Jäger, D, Mühlradt, P F, Büchler, M W, Märten, A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2007
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360370/ https://www.ncbi.nlm.nih.gov/pubmed/17667928 http://dx.doi.org/10.1038/sj.bjc.6603903

Ejemplares similares

Isolation, Structure Elucidation, and Synthesis of a Macrophage Stimulatory Lipopeptide from Mycoplasma fermentans Acting at Picomolar Concentration
por: Mühlradt, Peter F., et al.
Publicado: (1997)

Modulating the Tumour Microenvironment by Intratumoural Injection of Pattern Recognition Receptor Agonists
por: Burn, Olivia K., et al.
Publicado: (2020)

The Combination Immunotherapy of TLR9 Agonist and OX40 Agonist via Intratumoural Injection for Hepatocellular Carcinoma
por: Zhou, Zhimei, et al.
Publicado: (2021)

Intratumour microbiome of pancreatic cancer
por: Guan, Shi-Wei, et al.
Publicado: (2023)

Assessment of the Impact of a Toll-like Receptor 2 Agonist Synthetic Lipopeptide on Macrophage Susceptibility and Responses to African Swine Fever Virus Infection
por: Franzoni, Giulia, et al.
Publicado: (2022)

Prevention and Mitigation of Acute Radiation Syndrome in Mice by Synthetic Lipopeptide Agonists of Toll-Like Receptor 2 (TLR2)
por: Shakhov, Alexander N., et al.
Publicado: (2012)

The Toll–Like Receptor 2/6 Agonist, FSL–1 Lipopeptide, Therapeutically Mitigates Acute Radiation Syndrome
por: Kurkjian, Cathryn J., et al.
Publicado: (2017)

Local hypoxia is produced at sites of intratumour injection
por: Olive, P L, et al.
Publicado: (2002)

Targeting Toll-Like Receptor 2: Polarization of Porcine Macrophages by a Mycoplasma-Derived Pam2cys Lipopeptide
por: Franzoni, Giulia, et al.
Publicado: (2021)

Toll-like receptor 2 activation depends on lipopeptide shedding by bacterial surfactants
por: Hanzelmann, Dennis, et al.
Publicado: (2016)

The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinoma
por: Evan, Theodore, et al.
Publicado: (2022)

Intratumoural injection of absolute alcohol in carcinoma of gastroesophageal junction for palliation of dysphagia
por: Ramakrishnaiah, Vishnu Prasad Nelamangala, et al.
Publicado: (2014)

Producing the appropriate model and drug for intratumoural ablation
por: Kosmidis, Christoforos, et al.
Publicado: (2020)

Multidimensional intratumour heterogeneity in neuroblastoma
por: von Stedingk, Kristoffer, et al.
Publicado: (2019)

Mild-stretch mechanical ventilation upregulates toll-like receptor 2 and sensitizes the lung to bacterial lipopeptide
por: Charles, Pierre-Emmanuel, et al.
Publicado: (2011)

Pushing the envelope: Immune mechanism and application landscape of macrophage-activating lipopeptide-2
por: Liao, Daoyong, et al.
Publicado: (2023)

Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity
por: Agarwal, Yash, et al.
Publicado: (2022)

Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effect
por: Prasit, Kef K, et al.
Publicado: (2022)

Intrahepatic fetus: unusual image of an intratumoural haemorrhage
por: Reyes, Queennie, et al.
Publicado: (2017)

Intratumoural microbiota: from theory to clinical application
por: Ji, Hao, et al.
Publicado: (2023)

The Lipopeptide MALP-2 Promotes Collateral Growth
por: Troidl, Kerstin, et al.
Publicado: (2020)

Intratumour injection of immunoglobulins labelled with the alpha-particle emitter 211At: analyses of tumour retention, microdistribution and growth delay.
por: Larsen, R. H., et al.
Publicado: (1998)

Feasibility of CT quantification of intratumoural (166)Ho-microspheres
por: C. Bakker, R., et al.
Publicado: (2020)

Intratumoural administration and tumour tissue targeting of cancer immunotherapies
por: Melero, Ignacio, et al.
Publicado: (2021)

Intratumour microbiota modulates adrenocortical cancer responsiveness to mitotane
por: Cantini, Giulia, et al.
Publicado: (2023)

Ultrashort Cationic Lipopeptides and Lipopeptoids Selectively Induce Cytokine Production in Macrophages
por: Findlay, Brandon, et al.
Publicado: (2013)

Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity
por: Hoefflin, Rouven, et al.
Publicado: (2016)

Toll-like receptor 2 agonists inhibit human fibrocyte differentiation
por: Maharjan, Anu S, et al.
Publicado: (2010)

Promising abscopal effect of combination therapy with thermal tumour ablation and intratumoural OK-432 injection in the rat osteosarcoma model
por: Iwai, Tadashi, et al.
Publicado: (2020)

A toll-like receptor agonist mimicking microbial signal to generate tumor-suppressive macrophages
por: Feng, Yanxian, et al.
Publicado: (2019)

Macrophage-Activating Lipopeptide-2 Requires Mal and PI3K for Efficient Induction of Heme Oxygenase-1
por: You, Xiaoxing, et al.
Publicado: (2014)

Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy
por: Elander, N. O., et al.
Publicado: (2018)

Breast Carcinoma, Intratumour Heterogeneity and Histological Grading, Using Geostatistics
por: Sharifi‐Salamatian, Vénus, et al.
Publicado: (2000)

popFBA: tackling intratumour heterogeneity with Flux Balance Analysis
por: Damiani, Chiara, et al.
Publicado: (2017)

Intratumoural production of TNFα by bacteria mediates cancer therapy
por: Murphy, Carola, et al.
Publicado: (2017)

Use of the Intratumoural Anticancer Drug Tigilanol Tiglate in Two Horses
por: De Ridder, Thomas, et al.
Publicado: (2020)

Intratumour heterogeneity in microRNAs expression regulates glioblastoma metabolism
por: Alfardus, Huda, et al.
Publicado: (2021)

Bronchoscopic intratumoural therapies for non-small cell lung cancer
por: DeMaio, Andrew, et al.
Publicado: (2020)

Lipopeptides for Vaccine Development
por: Hamley, Ian W.
Publicado: (2021)

Single nucleotide polymorphisms in toll-like receptor 6 are associated with altered lipopeptide- and mycobacteria-induced IL-6 secretion
por: Shehu Shey, Muki, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_89b3m3cghc7th0nitcsoeoq0cn